Thymoglobulin, sirolimus, and reduced-dose cyclosporine provides excellent rejection prophylaxis for pancreas transplantation Academic Article uri icon

Overview

MeSH Major

  • Antilymphocyte Serum
  • Cyclosporine
  • Graft Rejection
  • Immunosuppressive Agents
  • Pancreas Transplantation
  • Sirolimus
  • T-Lymphocytes

abstract

  • This immunosuppressive regimen provided excellent prophylaxis against acute rejection with no opportunistic infections. We believe that careful monitoring of sirolimus and cyclosporine levels was critical to success of this protocol.

publication date

  • April 27, 2003

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1097/01.TP.0000061768.98058.EC

PubMed ID

  • 12717220

Additional Document Info

start page

  • 1301

end page

  • 6

volume

  • 75

number

  • 8